<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://newdrugapprovals.org/2026/04/03/anvumetostat/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-03T02:48:41+00:00</news:publication_date><news:title>Anvumetostat</news:title><news:keywords>Antineoplastic, ANAX LAB, QAT649EJ5E, AMG 193, PRMT5-IN-27, anvumetostat</news:keywords></news:news></url><url><loc>https://newdrugapprovals.org/2026/04/02/andamertinib/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-02T02:27:35+00:00</news:publication_date><news:title>Andamertinib</news:title><news:keywords>Antineoplastic, PLB 1004</news:keywords></news:news></url></urlset>
